drugset / Trial / NCT05444218

Surgical Access Combined With Systematically Administered Antibiotics in the Treatment of Peri-implantitis

NCT05444218

RandomizedParallel-groupTriple-blindTreatment

Summary

This randomized clinical trial evaluates the clinical and microbiological (microbial complexes and changes in the diversity of the submucosal biofilm) effects of MTZ+AMX as adjuncts to anti-infectious surgical treatment plus Er: YAG in the treatment of peri-implantitis.

Timeline

Start
2021-05-01
Primary completion
2024-07-16
Completion
2024-07-16

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 500 mg
Subject Metronidazole Small molecule 400 mg

Indications